In memory of their daughter, Vivian Grace, members of the Castaneda Family, of Glen Rock, NJ, recently held a book…
News
News
Carfilzomib-based therapy extends OS in relapsed, refractory multiple Myeloma
“This study provides further evidence that carfilzomib-based regimens are among the most potent in our multiple myeloma armamentarium,” David S….
Spring Allergies
Are your allergies making you miserable? You’re not alone. Pollen allergies tend to be worse in the spring, as plants…
Hackensack Meridian Health Co-CEO Robert C. Garrett Plays Key Role at National Innovation Conference
Robert C. Garrett appears at HLTH, the Future of Healthcare national conference with leading U.S. executives representing CVS, AETNA, Microsoft…
Dr. Goy Discusses the Evolution of Treatment for MCL
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the evolving treatment landscape…
Carfilzomib-based therapy extends OS in relapsed, refractory multiple Myeloma
“This study provides further evidence that carfilzomib-based regimens are among the most potent in our multiple myeloma armamentarium,” David S….
Hackensack Meridian Health Co-CEO Robert C. Garrett Honored at NJ Walk to Cure Arthritis
More than 1,000 people participated at the event in West Orange that will raise $300,000 to support the Arthritis Foundation’s…
Hackensack University Medical Center Installs Siemens’ Biograph Horizon
As part of an ongoing effort to offer patients the latest medical imaging technology available, the Department of Radiology at…
Hackensack University Medical Center Once Again Named as One of the 100 Great Hospitals in America
For the eighth year in a row, Hackensack Meridian Health Hackensack University Medical Center has been named to Becker’s Healthcare…
Expert Weighs In on What’s Next for Mantle Cell Lymphoma
The field of mantle cell lymphoma (MCL) is quickly growing, especially with new drug breakthroughs, prognostic biomarkers and next-generation sequencing,…